Search Result "Cholesterol retention modified LDL"
Fluid-Phase Pinocytosis of LDL by Macrophages: A Novel Target to Reduce Macrophage Cholesterol Accumulation in Atherosclerotic Lesions
Journal: Current Pharmaceutical Design
Volume: 19 Issue: 3 Year: 2013 Page: 5865-5872
Author(s): Howar S. Kruth
Possible Non-Classic Intracellular and Molecular Mechanisms of LDL Cholesterol Action Contributing to the Development and Progression of Atherosclerosis
Journal: Current Vascular Pharmacology
Volume: 2 Issue: 4 Year: 2004 Page: 363-370
Author(s): Ioanna Gouni-Berthold, Agapios Sachinidis
Recent Advances on Detection of Modified Forms of Low-Density Lipoproteins
Journal: Recent Patents on Endocrine, Metabolic & Immune Drug Discovery
Volume: 3 Issue: 1 Year: 2009 Page: 28-34
Author(s): Tanize E.S. Faulin, Maria C.C. Garcia, Dulcineia S.P. Abdalla
Misfolding of Apoprotein B-100, LDL Aggregation and 17-β -estradiol in Atherogenesis
Journal: Current Medicinal Chemistry
Volume: 21 Issue: 20 Year: 2014 Page: 2276-2283
Author(s): R. Brunelli,M. De Spirito,G. Mei,M. Papi,G. Perrone,C. Stefanutti,T. Parasassi
Role of Ox-LDL and LOX-1 in Atherogenesis
Journal: Current Medicinal Chemistry
Volume: 26 Issue: 9 Year: 2019 Page: 1693-1700
Author(s): Ajoe John Kattoor,Sri Harsha Kanuri,Jawahar L. Mehta
Assessment of Modes of Action and Efficacy of Plasma Cholesterol- Lowering Drugs: Measurement of Cholesterol Absorption, Cholesterol Synthesis and Bile Acid Synthesis and Turnover Using Novel Stable Isotope Techniques
Journal: Current Drug Targets - Immune, Endocrine & Metabolic Disorders
Volume: 5 Issue: 2 Year: 2005 Page: 209-218
Author(s): Frans Stellaard, Folkert Kuipers
Cholesterol Homeostasis and Liver X Receptor (LXR) in Atherosclerosis
Journal: Cardiovascular & Hematological Disorders-Drug Targets
Volume: 18 Issue: 1 Year: 2018 Page: 27-33
Author(s): Shuyuan Guo,Luxiao Li,Huiyong Yin
Cholesterol in Alzheimers Disease: Unresolved Questions
Journal: Current Alzheimer Research
Volume: 6 Issue: 1 Year: 2009 Page: 15-29
Author(s): Massimo Stefani, Gianfranco Liguri
“European Panel on Low Density Lipoprotein (LDL) Subclasses”: A Statement on the Pathophysiology, Atherogenicity and Clinical Significance of LDL Subclasses
Journal: Current Vascular Pharmacology
Volume: 9 Issue: 5 Year: 2011 Page: 533-571
Author(s): Dimitri P. Mikhailidis, Moses Elisaf, Manfredi Rizzo, Kaspar Berneis, Bruce Griffin, Alberto Zambon, Vasilios Athyros, Jacqueline de Graaf, Winfried Marz, Klaus G. Parhofer, Giovam Battista Rini, Giatgen A. Spinas, Gerald H. Tomkin, Alexandros D. Tselepis, Anthony S. Wierzbicki, Karl Winkler, Matilda Florentin, Evangelos Liberopoulos
Oxidized LDL Antibodies in Treatment and Risk Assessment of Atherosclerosis and Associated Cardiovascular Disease
Journal: Current Pharmaceutical Design
Volume: 13 Issue: 1 Year: 2007 Page: 1021-1030
Author(s): Jan Nilsson, Gunilla Nordin Fredrikson, Alexandru Schiopu, Prediman K. Shah, Bo Jansson, Roland Carlsson